Clinical trials
Observational Heart Failure, Diastolic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2017 | 1 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 8 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Unknown status | 11 |
| Recruiting | 10 |
| Not yet recruiting | 6 |
| Active, not recruiting | 5 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Herlev and Gentofte Hospital | 3 |
| Assiut University | 2 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 2 |
| Mayo Clinic | 2 |
| AdventHealth | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Boston Scientific Corporation | 1 |
| CES University | 1 |
| Duyen Nguyen Hoang Mai | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure, Diastolic | 55 |
| Heart Failure | 23 |
| Heart Failure, Systolic | 16 |
| Ventricular Dysfunction, Left | 5 |
| Heart Diseases | 4 |
| Myocardial Infarction | 4 |
| Stroke | 4 |
| Atrial Fibrillation | 3 |
| Cardiovascular Diseases | 3 |
| Hypertension | 3 |
Trials
Showing 51 to 55 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.